Ticker Details
Keros Therapeutics, Inc.
IPO Date:	April 8, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$493.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.11 | 2.63%
Avg Daily Range (30 D):	$0.30 | 1.65%
Avg Daily Range (90 D):	$0.37 | 2.10%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.62M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	2,091
Avg Institutional Trade:	$1.89M
Avg Institutional Trade (30 D):	$.89M
Avg Institutional Trade (90 D):	$2.23M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.94M
Avg Closing Trade (30 D):	$.93M
Avg Closing Trade (90 D):	$2.22M
Avg Closing Volume:	59.96K

News

Nov 20, 2025 @ 9:01 PM Keros Therapeutics Announces Final Results of Tend... Source: Globe Newswire

Nov 19, 2025 @ 11:00 AM Keros Therapeutics Announces Preliminary Results o... Source: Keros Therapeutics, Inc.

Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight

May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc.

May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.18	$-.76	$3.66
Diluted EPS	$-.18	$-.76	$3.62
Revenue	$14.12M	$18.17M	$211.19M
Gross Profit
Net Income / Loss	$-7.28M	$-30.7M	$148.45M
Operating Income / Loss	$-15.38M	$-39.82M	$152.04M
Cost of Revenue
Net Cash Flow	$3.26M	$-30.33M	$160.61M
PE Ratio